Clinical efficacy of sublingual immunotherapy tablets for allergic rhinitis is unlikely to be derived from in vitro allergen-release data - Archive ouverte HAL
Article Dans Une Revue Expert Review of Clinical Immunology Année : 2019

Clinical efficacy of sublingual immunotherapy tablets for allergic rhinitis is unlikely to be derived from in vitro allergen-release data

Giorgio Walter Canonica
Philippe Devillier
Unité de recherche Virologie et Immunologie Moléculaires
Hôpital Foch [Suresnes]
Thomas Casale
Pascal Demoly
CHU Montpellier = Montpellier University Hospital
Institut Desbrest de santé publique
CV
Catherine Bos
Efstrathios Karagiannis
Giovanni Passalacqua
Ulrich Wahn
Laurent Mascarell

Domaines

Sciences du Vivant [q-bio] Sciences de l'Homme et Société

Philippe Devillier  : Connectez-vous pour contacter le contributeur

https://hal.science/hal-04265141

Soumis le : lundi 30 octobre 2023-16:39:41

Dernière modification le : mardi 26 novembre 2024-15:54:03

Consulter le texte intégral

Dates et versions

hal-04265141 , version 1 (30-10-2023)

Identifiants

Citer

Giorgio Walter Canonica, Philippe Devillier, Thomas Casale, Pascal Demoly, Catherine Bos, et al.. Clinical efficacy of sublingual immunotherapy tablets for allergic rhinitis is unlikely to be derived from in vitro allergen-release data. Expert Review of Clinical Immunology, 2019, 15 (9), pp.921-928. ⟨10.1080/1744666X.2019.1649597⟩. ⟨hal-04265141⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

INRA UNIV-PARIS-SACLAY UNIV-MONTPELLIER INRAE VIM GS-HEALTH-DRUG-SCIENCES
11 Consultations
0 Téléchargements

Altmetric

Partager

More